Synovus announces CEO Kevin Blair to additional role of Chairman of the Board of Directors

– USA, GA –  Synovus Financial Corp. (NYSE: SNV) today announced the appointment of President and CEO Kevin Blair as the Chairman of the Board of Directors, effective Jan. 1st, 2023 to succeed Kessel Stelling who is retiring from the Board on Dec. 31, 2022.

About Kevin Blair

Kevin Blair has served as president and CEO of Synovus since April 2021. He joined Synovus in 2016 as EVP and CFO. Blair was appointed senior EVP, COO in 2018.

“I’m honored to expand my executive responsibilities to include board chair, succeeding a highly respected leader whose legacy is marked by strength, resiliency and a commitment to the continued success of our company and investment in our people,” said Kevin Blair. “Kessel has also been instrumental in building a talented, diverse and cohesive board that is deeply committed to strong governance practices. I look forward to the continued work with our directors and executive team to effectively execute our key strategic growth initiatives.”

About Synovus Financial Corp.

Synovus Financial Corp. is a financial services company based in Columbus, Georgia, with approximately $59 billion in assets. Synovus provides commercial and consumer banking and a full suite of specialized products and services, including private banking, treasury management, wealth management, mortgage services, premium finance, asset-based lending, structured lending, capital markets and international banking. Synovus has branches in Georgia, Alabama, South Carolina, Florida and Tennessee.

For more information : https://www.synovus.com/

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.